WallStSmart
RKDA

Arcadia Biosciences Inc

NASDAQ: RKDA · CONSUMER DEFENSIVE · PACKAGED FOODS

$1.05
-0.94% today

Updated 2026-04-30

Market cap
$2.20M
P/E ratio
P/S ratio
0.45x
EPS (TTM)
$-1.71
Dividend yield
52W range
$1 – $6
Volume
0.0M

Arcadia Biosciences Inc (RKDA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+66.2%
Last 4 quarters
Revenue YoY growth
-25.9%
Most recent quarter
EPS YoY growth
+67.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-11.0%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-14.5%
2026-03-27
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-27$-0.98$1.52$1.30-14.5%
2025-11-07$0.62+166.0%$3.90$3.61-7.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.98$901000.00-25.9%
2025-09-30$-0.94$0.62+166.0%$1.30M-15.3%
2025-06-30$-1.22$-3.26-167.2%$1.46M+11.4%
2025-03-31$-0.98$1.90+293.9%$1.20M+21.6%
2024-12-31$-0.89$-2.99-236.0%$1.22M+3.9%
2024-09-30$-0.81$-0.87-7.4%$1.54M+18.4%
2024-06-30$1.55$0.78-49.7%$1.31M+0.7%
2024-03-31$-2.21$-1.78+19.5%$987000.00-19.9%
2023-12-31$-2.58$-2.52+2.3%$1.17M
2023-09-30$-3.19$-1.44+54.9%$1.30M
2023-06-30$-4.80$-2.65+44.8%$1.30M
2023-03-31$-6.85$-10.86-58.5%$1.23M

Frequently asked questions

Has Arcadia Biosciences Inc beaten earnings estimates?
Arcadia Biosciences Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +66.2% over the last 3 quarters.
How does RKDA stock react to earnings?
RKDA stock has moved an average of -11.0% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Arcadia Biosciences Inc's revenue growth rate?
Arcadia Biosciences Inc reported year-over-year revenue growth of -25.9% in its most recent quarter, with EPS growing +67.4% year-over-year.